Clinical Trial Update: Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating pelvic hypofractionated radiotherapy for endometrial cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Snippet

Sponsor: University of Chicago | Conditions: Endometrial Cancer | Phase 1, Phase 2 | Status: RECRUITING